A specialized platform for rare disease patients to aggregate data, match with precision trials, and push research forward.
Three years ago, my family was diagnosed with a rare disease. We spent months collecting information—10+ doctor visits with contradictory advice, piles of medical research papers we couldn't understand, and clinical trials websites that were scattered, outdated, and overwhelming.
We realized that the system relies on patients doing the heavy lifting. But patients are the ones who are sick, tired, and overwhelmed.
ResearchBridge exists to change that dynamic. We are the bridge between patients and clinical research. We translate the science, organize the data, and illuminate the path forward.
We don't just "list features." We solve the specific, painful problems of navigating a rare disease diagnosis.
ResearchBridge becomes your personal research vault. Securely store genetic reports, medication history, and test results in one place. No more scattered documents.
Our algorithm analyzes 50,000+ active clinical trials and identifies matches based on YOUR genetic profile.
We break down complex genetic science into plain language. Understand exactly what the treatment does without the headache.
Walk into appointments prepared. We give you specific questions to ask based on your matches.
ResearchBridge applies methodologies developed by leading rare disease researchers. We stay current with the latest genetic research and clinical best practices. Here are key researchers whose work informs our approach:
Genetic counseling with genome sequencing in pediatric rare disease. Led GenCOUNSEL, the largest genetic counselling research grant. Published foundational work on optimizing genetic counseling for rare disease diagnosis.
Pioneer in gene therapy for rare neurological diseases. Director of UT Southwestern's Gene Therapy Program. Developed AAV gene therapy approaches for Giant Axonal Neuropathy and Batten disease.
Division Chief of Pediatric Neurology. Discovered genes responsible for Lafora disease. Co-leads UT Southwestern's Gene Therapy Program. Specializes in neurogenetic conditions and rare epilepsy disorders.
We strip away the jargon so you can focus on the opportunity.
This study tests a new medication that may reduce joint pain for patients who haven't responded to standard therapy.
We analyze the world's largest research databases in real-time to find YOUR perfect match.
Trusted sources. Human review. Your understanding.
We're building in public. We are taking the time to do this right.
Open enrollment for all rare disease patients globally.
We believe rare disease patients shouldn't have to pay for survival information.
Join our founding cohort launching Q2 2026. Be among the first to use ResearchBridge.
Early access signups opening soon. No credit card required.